drugset / Trial / NCT03352349

Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection

NCT03352349 ↗

Phase 2 Unknown 30 enrolled Shanghai Zhongshan Hospital
NaSingle-groupOpen-labelTreatment

Summary

In this study, investigators aim to screen out the patients with portal hypertension by monitoring intraoperative PVP, and to decide the effect of Terlipressinum on the portal pressure after liver resection.

Timeline

Start
2017-12-01
Primary completion
2018-10-30
Completion
2018-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressinum Unknown 2 mg Intravenous

Indications